Patent · US Active

TRPA1 receptor antagonist

US8859556B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

Acturum Life Science AB · SE

Inventors

Mats A. Svensson · New York, US
Dirk Reinhold Weigelt · Åkersberga, SE

Key dates

Filing date	Oct 11, 2011
Grant date	Oct 14, 2014
Priority date	—
Expiry date	Oct 11, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of Formula (I), pharmaceutically acceptable salts thereof, enantiomers, or mixtures thereof; pharmaceutical compositions containing said compounds, enantiomers or mixtures; processes for making said compounds, enantiomers or mixtures; the use of said compounds, enantiomers or mixtures; and medicaments containing the same for treatment of pain and other conditions; and methods of treating pain and other conditions with the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.